Why Evolus Shares Are Trading Higher Today


Evolus, Inc. EOLS shares are trading higher after the company issued fourth-quarter and full-year 2022 and announced full-year 2023 revenue guidance.

What happened: On Wednesday, Evolus issued its fourth-quarter 2022 and full-year 2022 preliminary unaudited net revenue results. Net revenue for the fourth quarter of 2022 is estimated at $43.6 million, a 26% increase from the same period in 2021. Full-year net revenue is approximately $148.6 million, a 49% increase from full-year 2021.

Additionally, the company also issued revenue guidance for the full-year 2023. Total net revenues for 2023 are estimated to be between $180 million and $190 million, and Evolus expects non-GAAP operating income to be positive in the fourth quarter of 2023.

David Moatazedi, President and CEO of Evolus, noted that “during the [fourth] quarter, we continued to add customer accounts and expand our consumer loyalty program…this helped drive sales growth well above the projected growth rate of our industry.”

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market.

According to Benzinga Pro data, Evolus Inc. shares were up 17.5%, trading at $9.94 at the time of publication. It has a 52-week high of $10.15 and a 52-week low of $8.65.

Market News and Data brought to you by Benzinga APIs
Posted In: Small CapMoversTrading Ideaswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!